# Risk Factors and Impact MASLD in Patients With IBD

> **NCT06328452** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 120 (estimated)

## Conditions studied

- Metabolic Dysfunction-associated Steatotic Liver Disease

## Interventions

- **DEVICE:** FibroScan

## Key facts

- **NCT ID:** NCT06328452
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06328452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06328452, "Risk Factors and Impact MASLD in Patients With IBD". Retrieved via AI Analytics 2026-09-13 from https://api.ai-analytics.org/clinical/NCT06328452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
